Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Dare Bioscience's price to sales ratio was 7.7× on Nov 11, 2026, against 127.5× a year earlier. Over the last 3 years it ranged from 6.4× to 150.6×, with a median of 14.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.7× | −7.1 |
| 2025 | Jan 31, 2025 | 14.8× | +0.6 |
| 2024 | Dec 31, 2024 | 14.2× | −16.2 |
| 2023 | Dec 29, 2023 | 30.4× | +23.8 |
| 2017 | Apr 28, 2017 | 6.6× | – |
See a number that looks wrong?